Logo image
Analysis of Nevirapine Resistance Mutations in Cloned HIV Type 1 Variants from HIV-Infected Ugandan Infants Using a Single-Step Amplification-Sequencing Method (AmpliSeq)
Journal article   Open access   Peer reviewed

Analysis of Nevirapine Resistance Mutations in Cloned HIV Type 1 Variants from HIV-Infected Ugandan Infants Using a Single-Step Amplification-Sequencing Method (AmpliSeq)

William Ian TOWLER, Jessica D CHURCH, James R ESHLEMAN, Mary Glenn FOWLER, Laura A GUAY, J. Brooks JACKSON and Susan H ESHLEMAN
AIDS research and human retroviruses, Vol.24(9), pp.1209-1213
2008
DOI: 10.1089/aid.2008.0109
PMCID: PMC2562759
PMID: 18788912
url
https://doi.org/10.1089/aid.2008.0109View
Published (Version of record) Open Access

Abstract

We analyzed the genetic linkage of nevirapine (NVP) resistance mutations and the genetic complexity of HIV-1 variants in Ugandan infants who were HIV infected despite single dose (SD) prophylaxis. Plasma samples were obtained from six HIV-infected infants who had two or more NVP resistance mutations detected by population sequencing (ViroSeq). ViroSeq PCR products were cloned and transformed, and a single-step amplification-sequencing reaction (AmpliSeq) was used to analyze NVP resistance mutations in cloned HIV-1 variants directly from bacterial colonies. Fifty clones were analyzed for each infant sample. This analysis revealed numerous NVP resistance mutations not detected by population sequencing, genetically linked NVP resistance mutations, and a high degree of genetic complexity at codons that influence NVP susceptibility.
Infectious Diseases Microbiology Virology Fundamental and applied biological sciences. Psychology Action of physical and chemical agents Miscellaneous Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Biological and medical sciences Medical sciences Human viral diseases

Details

Metrics

Logo image